Yisheng Biopharma Overview

  • Founded
  • 1994
Founded
  • Status
  • Private
  • Employees
  • 500
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $130M
Latest Deal Amount
  • Investors
  • 11

Yisheng Biopharma General Information

Description

Developer and manufacturer of immunotherapeutic drugs and vaccines intended for the treatment of tumours and rare diseases. The company focuses on research, development, manufacturing, sales and marketing of immunological biologics, enabling doctors to provide patients with effective treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 38 Yongda Road. Daxing Biomedical Industrial Park
  • Daxing District
  • Beijing, 102600
  • China
+86 400 000 0000

Yisheng Biopharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Yisheng Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 24-Feb-2021 $130M 00000 Completed Generating Revenue
2. Later Stage VC 10-Jul-2020 0000 0000 Completed Generating Revenue
1. Later Stage VC 01-Jan-2012 Completed Generating Revenue
To view Yisheng Biopharma’s complete valuation and funding history, request access »

Yisheng Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and manufacturer of immunotherapeutic drugs and vaccines intended for the treatment of tumours and rare diseas
Drug Discovery
Beijing, China
500 As of 2021
00000
00000000000 00000

000000 0

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000

00000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000000000000
Beijing, China
00 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Yisheng Biopharma Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corvus Pharmaceuticals Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
00000000 0000000 Private Equity-Backed Beijing, China 00 00000 0000000 0000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 31 competitors. Get the full list »

Yisheng Biopharma Patents

Yisheng Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3740234-A1 Method for adapting influenza viruses to vero cells Pending 18-Jan-2018 0000000000
US-20210106672-A1 Method for adapting influenza viruses to vero cells Pending 18-Jan-2018 000000000
US-20200222529-A1 Composition for treating and/or preventing hepatitis b virus infection and the use thereof Pending 10-Aug-2017 0000000000
EP-3664840-A1 A composition for treating and/or preventing hepatitis b virus infection and the use thereof Pending 10-Aug-2017 0000000000
CA-3070935-A1 A composition for treating and/or preventing hepatitis b virus infection and the use thereof Pending 10-Aug-2017 A61P37/04

Yisheng Biopharma Executive Team (2)

Name Title Board Seat Contact Info
Hui Shao Ph.D Chief Executive Officer & President
Yi Zhang Founder & Chairman
To view Yisheng Biopharma’s complete executive team members history, request access »

Yisheng Biopharma Board Members (1)

Name Representing Role Since
Yi Zhang Yisheng Biopharma Founder & Chairman 000 0000
To view Yisheng Biopharma’s complete board members history, request access »

Yisheng Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yisheng Biopharma Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3W Partners Capital PE/Buyout Minority 000 0000 000000 0
Epiphron Capital Venture Capital Minority 000 0000 000000 0
F-Prime Capital Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
HT Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »